Alivus Life Sciences Limited (NSE:ALIVUS)
883.50
+22.00 (2.55%)
Jan 23, 2026, 3:29 PM IST
-21.30% (1Y)
| Market Cap | 108.44B |
| Revenue (ttm) | 25.12B |
| Net Income (ttm) | 5.44B |
| Shares Out | 122.74M |
| EPS (ttm) | 44.23 |
| PE Ratio | 19.97 |
| Forward PE | 17.68 |
| Dividend | 5.00 (0.58%) |
| Ex-Dividend Date | Sep 1, 2025 |
| Volume | 208,914 |
| Average Volume | 62,671 |
| Open | 887.00 |
| Previous Close | 861.50 |
| Day's Range | 861.50 - 909.40 |
| 52-Week Range | 819.00 - 1,251.00 |
| Beta | 0.08 |
| RSI | 49.64 |
| Earnings Date | Jan 22, 2026 |